journal
https://read.qxmd.com/read/38347167/thyroid-dysfunction-in-covid-19
#21
REVIEW
David Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, Ivan Fan Ngai Hung, Karen Siu Ling Lam
The COVID-19 pandemic has affected over 772 million people globally. While lung damage is the major contributor to the morbidity and mortality of this disease, the involvement of multiple organs, including the endocrine glands, has been reported. This Review aims to provide an updated summary of evidence regarding COVID-19 and thyroid dysfunction, incorporating highlights of recent advances in the field, particularly in relation to long COVID and COVID-19 vaccination. Since subacute thyroiditis following COVID-19 was first reported in May 2020, thyroid dysfunction associated with COVID-19 has been increasingly recognized, secondary to direct and indirect effects on the hypothalamic-pituitary-thyroid axis...
February 12, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38336898/consensus-guideline-for-the-diagnosis-and-management-of-pituitary-adenomas-in-childhood-and-adolescence-part-2-specific-diseases
#22
REVIEW
Márta Korbonits, Joanne C Blair, Anna Boguslawska, John Ayuk, Justin H Davies, Maralyn R Druce, Jane Evanson, Daniel Flanagan, Nigel Glynn, Claire E Higham, Thomas S Jacques, Saurabh Sinha, Ian Simmons, Nicky Thorp, Francesca M Swords, Helen L Storr, Helen A Spoudeas
Pituitary adenomas are rare in children and young people under the age of 19 (hereafter referred to as CYP) but they pose some different diagnostic and management challenges in this age group than in adults. These rare neoplasms can disrupt maturational, visual, intellectual and developmental processes and, in CYP, they tend to have more occult presentation, aggressive behaviour and are more likely to have a genetic basis than in adults. Through standardized AGREE II methodology, literature review and Delphi consensus, a multidisciplinary expert group developed 74 pragmatic management recommendations aimed at optimizing care for CYP in the first-ever comprehensive consensus guideline to cover the care of CYP with pituitary adenoma...
February 9, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38336897/consensus-guideline-for-the-diagnosis-and-management-of-pituitary-adenomas-in-childhood-and-adolescence-part%C3%A2-1-general-recommendations
#23
REVIEW
Márta Korbonits, Joanne C Blair, Anna Boguslawska, John Ayuk, Justin H Davies, Maralyn R Druce, Jane Evanson, Daniel Flanagan, Nigel Glynn, Claire E Higham, Thomas S Jacques, Saurabh Sinha, Ian Simmons, Nicky Thorp, Francesca M Swords, Helen L Storr, Helen A Spoudeas
Tumours of the anterior part of the pituitary gland represent just 1% of all childhood (aged <15 years) intracranial neoplasms, yet they can confer high morbidity and little evidence and guidance is in place for their management. Between 2014 and 2022, a multidisciplinary expert group systematically developed the first comprehensive clinical practice consensus guideline for children and young people under the age 19 years (hereafter referred to as CYP) presenting with a suspected pituitary adenoma to inform specialist care and improve health outcomes...
February 9, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38321142/sarcopenic-obesity-in-older-adults-a-clinical-overview
#24
REVIEW
Carla M Prado, John A Batsis, Lorenzo M Donini, M Cristina Gonzalez, Mario Siervo
Sarcopenic obesity is characterized by a concurrent decline in muscle mass and function, along with increased adipose tissue. Sarcopenic obesity is a growing concern in older adults owing to significant health consequences, including implications for mortality, comorbidities and risk of developing geriatric syndromes. A 2022 consensus statement established a new definition and diagnostic criteria for sarcopenic obesity. The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others...
February 6, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38316919/author-correction-seeing-through-the-fog-a-neuroendocrine-explanation-for-post-covid-cognitive-deficits
#25
S Rasika, Ruben Nogueiras, Markus Schwaninger, Vincent Prevot
No abstract text is available yet for this article.
February 5, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38308073/targeting-endometriosis
#26
JOURNAL ARTICLE
Claire Greenhill
No abstract text is available yet for this article.
February 2, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38308072/dysfunctional-lipid-metabolism-in-ageing-muscle-effects-on-glucose-tolerance
#27
JOURNAL ARTICLE
Shimona Starling
No abstract text is available yet for this article.
February 2, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38302586/pancreatic-%C3%AE-cells-influence-the-glycaemic-set-point
#28
JOURNAL ARTICLE
Olivia Tysoe
No abstract text is available yet for this article.
February 1, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38287186/seeing-through-the-fog-a-neuroendocrine-explanation-for-post-covid-cognitive-deficits
#29
JOURNAL ARTICLE
S Rasika, Ruben Nogueiras, Markus Scwaninger, Vincent Prevot
No abstract text is available yet for this article.
January 29, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38272995/iatrogenic-adrenal-insufficiency-in-adults
#30
REVIEW
Julie Martin-Grace, Maria Tomkins, Michael W O'Reilly, Mark Sherlock
Iatrogenic adrenal insufficiency (IAI) is the most common form of adrenal insufficiency in adult patients, although its overall exact prevalence remains unclear. IAI is associated with adverse clinical outcomes, including adrenal crisis, impaired quality of life and increased mortality; therefore, it is imperative that clinicians maintain a high index of suspicion in patients at risk of IAI to facilitate timely diagnosis and appropriate management. Herein, we review the major causes, clinical consequences, diagnosis and care of patients with IAI...
January 25, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38253862/reply-to-the-shift-of-therapeutic-strategy-for-prolactinomas-surgery-as-the-first-line-option
#31
LETTER
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
No abstract text is available yet for this article.
January 22, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38253861/the-shift-of-therapeutic-strategy-for-prolactinomas-surgery-as-the-first-line-option
#32
LETTER
Zhe Bao Wu
No abstract text is available yet for this article.
January 22, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38253860/a-view-on-vitamin-d-a-pleiotropic-factor
#33
JOURNAL ARTICLE
Andrea Giustina, Marise Lazaretti-Castro, Adrian R Martineau, Rebecca S Mason, Clifford J Rosen, Inez Schoenmakers
No abstract text is available yet for this article.
January 22, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38225400/mtorc1-in-energy-expenditure-consequences-for-obesity
#34
REVIEW
Camille Allard, Cristina Miralpeix, Antonio J López-Gambero, Daniela Cota
In eukaryotic cells, the mammalian target of rapamycin complex 1 (sometimes referred to as the mechanistic target of rapamycin complex 1; mTORC1) orchestrates cellular metabolism in response to environmental energy availability. As a result, at the organismal level, mTORC1 signalling regulates the intake, storage and use of energy by acting as a hub for the actions of nutrients and hormones, such as leptin and insulin, in different cell types. It is therefore unsurprising that deregulated mTORC1 signalling is associated with obesity...
January 15, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38212357/brain-immune-networks-a-role-for-glp1-receptor
#35
JOURNAL ARTICLE
Claire Greenhill
No abstract text is available yet for this article.
January 11, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38191657/phospholipid-biosynthetic-pathways-and-lipodystrophies-a-novel-syndrome-due-to-plaat3-deficiency
#36
JOURNAL ARTICLE
Anil K Agarwal, Abhimanyu Garg
No abstract text is available yet for this article.
January 8, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38182747/scrutinizing-the-effect-of-bps-on-adipose-tissue
#37
JOURNAL ARTICLE
Shimona Starling
No abstract text is available yet for this article.
January 5, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38182746/organoids-in-endocrine-and-metabolic-research-current-and-emerging-applications
#38
JOURNAL ARTICLE
Penney M Gilbert, Sandra Hofmann, Huck-Hui Ng, Hugo Vankelecom, James M Wells
No abstract text is available yet for this article.
January 5, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38182745/oxytocin-regulates-adipose-tissue-lipolysis
#39
JOURNAL ARTICLE
Olivia Tysoe
No abstract text is available yet for this article.
January 5, 2024: Nature Reviews. Endocrinology
https://read.qxmd.com/read/38182744/a-transporter-on-the-move
#40
JOURNAL ARTICLE
Steffen H Raun
No abstract text is available yet for this article.
January 5, 2024: Nature Reviews. Endocrinology
journal
journal
42297
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.